- Home
- LENZ vs ACP Comparison
LENZ vs ACP Comparison
Compare LENZ & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | ACP |
|---|---|---|
| Founded | 2019 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 852.0M | 712.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LENZ | ACP |
|---|---|---|
| Price | $17.35 | $5.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $56.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 337.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $204.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.70 | $5.55 |
| 52 Week High | $50.40 | $7.17 |
Technical Indicators
Market Signals| Indicator | LENZ | ACP |
|---|---|---|
| Relative Strength Index (RSI) | 23.37 | 44.39 |
| Support Level | $15.70 | $5.37 |
| Resistance Level | $29.02 | $5.48 |
| Average True Range (ATR) | 2.37 | 0.05 |
| MACD | -0.91 | 0.01 |
| Stochastic Oscillator | 9.76 | 51.94 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.